|
Legal Proceedings (Narrative) (Details) (USD $)
|
0 Months Ended | 1 Months Ended | 0 Months Ended | |
|---|---|---|---|---|
|
Apr. 11, 2014
lawsuit
|
Feb. 28, 2014
plaintiff
lawsuit
|
Jun. 07, 2013
|
Mar. 31, 2015
|
|
| Andrulis Pharmaceuticals Corporation Patent Infringement | ||||
| Loss Contingencies [Line Items] | ||||
| Claims dismissed | 2 | |||
| Patents allegedly infringed | 4 | |||
| Litigation Related to Sales of THALOMID and REVLIMID | ||||
| Loss Contingencies [Line Items] | ||||
| Number of civil qui tam actions | 3 | |||
| Number of plaintiffs | 3 | |||
| Children's Medical Center Corporation | ||||
| Loss Contingencies [Line Items] | ||||
| Range of possible loss, minimum | $ 0 | |||
| Range of possible loss, maximum | $ 98,400,000.0 | |||
| Children's Medical Center Corporation | revlimid royalty | ||||
| Loss Contingencies [Line Items] | ||||
| Royalty rate | 0.01 | |||
| Children's Medical Center Corporation | pomalyst royalty | ||||
| Loss Contingencies [Line Items] | ||||
| Royalty rate | 0.025 |